News from boston scientific corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 02, 2022, 09:30 ET Boston Scientific to Participate in Bank of America Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) will participate in Bank of America's Global Healthcare Conference on Thursday, May 12. Dan Brennan,...

Apr 27, 2022, 06:30 ET BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing 10.0 percent on a reported...

Apr 01, 2022, 09:00 ET Boston Scientific Announces Conference Call Discussing First Quarter 2022 Results

Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial results and business highlights for the first quarter...

Mar 16, 2022, 16:58 ET Boston Scientific Announces Pricing Terms of Its Cash Tender Offer

Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced the pricing terms of the previously announced upsized cash tender offer (the ...

Mar 16, 2022, 06:30 ET Boston Scientific Announces Early Results of Its Cash Tender Offer for Its Outstanding Debt Securities and Increases Aggregate Maximum Principal Amount of Its Cash Tender Offer

Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced that, pursuant to the previously announced cash tender offer (the "Tender...

Mar 08, 2022, 16:30 ET Boston Scientific Announces Completion of €3.0 Billion Offering of Senior Notes

Boston Scientific Corporation (NYSE: BSX) (the "Company") today announced that American Medical Systems Europe B.V., its wholly owned finance...

Mar 04, 2022, 06:25 ET Boston Scientific Announces Pricing of €3.0 Billion of Senior Notes

Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V., its wholly owned finance...

Mar 02, 2022, 04:49 ET Boston Scientific Announces Cash Tender Offer for up to $2.5 Billion of Its Outstanding Debt Securities

Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced the commencement of a cash tender offer (the "Tender Offer") for up to $2.5...

Feb 28, 2022, 12:03 ET Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX™ LAAC Device

Boston Scientific Corporation (NYSE: BSX) today announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX™...

Feb 15, 2022, 07:00 ET Boston Scientific Closes Acquisition of Baylis Medical Company Inc.

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Baylis Medical Company Inc., a company that offers advanced ...

Feb 14, 2022, 09:30 ET Boston Scientific to Participate in 11th Annual SVB Leerink Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) will participate in SVB Leerink's 11th Annual Global Healthcare Conference on Thursday, February 17, 2022....

Feb 02, 2022, 06:30 ET Boston Scientific Announces Results For Fourth Quarter And Full Year 2021

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported ...

Jan 07, 2022, 07:00 ET Boston Scientific to Present New Data on Advances in Chronic Pain Care at the 2022 North American Neuromodulation Society (NANS) Meeting

Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society (NANS)...

Jan 04, 2022, 09:04 ET Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2021 Results

Boston Scientific Corporation (NYSE: BSX) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022. Mike...

Dec 02, 2021, 07:00 ET Boston Scientific Initiates Trial to Evaluate Industry's First Modular CRM System

Boston Scientific Corporation (NYSE: BSX) has initiated the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the...

Nov 08, 2021, 09:30 ET Boston Scientific Announces Upcoming Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On November 15, 2021, Dan Brennan, executive vice...

Oct 27, 2021, 06:30 ET Boston Scientific Announces Results For Third Quarter 2021

Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a reported...

Oct 06, 2021, 12:35 ET Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents

Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia™ Drug-Eluting Vascular Stent System (Eluvia stent) during a...

Oct 06, 2021, 07:00 ET Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for...

Oct 05, 2021, 16:21 ET Positive Late-breaking Clinical Trial Data for the EkoSonic™ Endovascular System Presented at VIVA21

Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic™ Endovascular System (EKOS system) during a late-breaking clinical...

Oct 05, 2021, 12:35 ET Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger™ Drug-Coated Balloon

Today, Boston Scientific (NYSE: BSX) announced positive results for the Ranger™ Drug-Coated Balloon (DCB) during a late-breaking clinical trial...

Oct 04, 2021, 10:30 ET Boston Scientific Announces Conference Call Discussing Third Quarter 2021 Results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ...

Sep 21, 2021, 07:00 ET Boston Scientific Announces Agreement to Acquire Devoro Medical, Inc.

Today, Boston Scientific Corporation (NYSE: BSX) announced an agreement to acquire Devoro Medical, Inc., developer of the WOLF Thrombectomy® Platform....

Sep 20, 2021, 07:36 ET Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres

Boston Scientific Corporation (NYSE: BSX) announced the EPOCH clinical trial of the TheraSphere™ Y-90 Glass Microspheres (TheraSphere treatment)...

Sep 09, 2021, 10:45 ET Boston Scientific Announces 2021 Investor Day Meeting

Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth...